heme has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, S; Bellstedt, P; Frey, S; Galler, K; Goradia, NB; Hampel, K; Hamza, I; Heinemann, SH; Hoffmann, P; Hueber, AJ; Imhof, D; Krönke, G; Kühl, T; Kumar, A; Neugebauer, U; Ohlenschläger, O; Paul George, AA; Popp, J; Ramachandran, R; Wiendl, M; Wißbrock, A; Zimmermann, B | 1 |
| Chen, H; Dai, Z; Han, L; Huang, H; Li, L; Lu, C; Lu, Y; Wang, A; Wei, J; Zhong, X | 1 |
2 other study(ies) available for heme and Psoriasis
| Article | Year |
|---|---|
Structural insights into heme binding to IL-36α proinflammatory cytokine.
Topics: Arthritis, Rheumatoid; Cells, Cultured; Cytokines; Fibroblasts; Heme; Humans; Inflammation Mediators; Interleukin-1; Models, Molecular; Molecular Dynamics Simulation; Protein Binding; Protein Conformation; Psoriasis; Structure-Activity Relationship; Synovial Membrane | 2019 |
Genistein suppresses psoriasis-related inflammation through a STAT3-NF-κB-dependent mechanism in keratinocytes.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cytokines; Disease Models, Animal; Genistein; Heme; Humans; Imiquimod; Inflammation Mediators; Keratinocytes; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Psoriasis; STAT3 Transcription Factor; Vascular Endothelial Growth Factor A | 2019 |